Like Src, previous studies have demonstrated that mammary-specific FAK deletion protects against MMTV-PyMT-driven tumors through inhibiting proliferation, and that autophosphorylation at Tyr397 is required for tumor development [63]. This evidence concerns the gene PTK2 and neoplasm.